Why menopause and perimenopause make weight loss more challenging Combining hormone replacement therapy (HRT) with glucagon-like peptide-1 (GLP-1) receptor agonists has become an increasingly common approach for treating menopausal weight gain, particularly stubborn visceral fat around the midsection
Its natural to worry when you're taking a new medication, especially when you hear about serious potential side effects
Assists with bariatric evaluation, preparation, and long-term nutrition planning
Reduced Hyperandrogenism Symptoms GLP-1 therapy also plays a role in reducing hyperandrogenism, a hallmark of PCOS that contributes to symptoms like excess facial hair, acne, and hair loss
Early consultation with your GP can facilitate timely diagnosis and access to appropriate management strategies
Patient Education and Support Patient education and support are integral to the successful implementation of new developments in Semaglutide therapy